These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 9285522

  • 1. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
    Gollapudi L, Neet KE.
    J Neurosci Res; 1997 Aug 15; 49(4):461-74. PubMed ID: 9285522
    [Abstract] [Full Text] [Related]

  • 2. Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells.
    Buchkovich KJ, Ziff EB.
    Mol Biol Cell; 1994 Nov 15; 5(11):1225-41. PubMed ID: 7865886
    [Abstract] [Full Text] [Related]

  • 3. Hierarchical analysis of the nerve growth factor-dependent and nerve growth factor-independent differentiation signaling pathways in PC12 cells with protein kinase inhibitors.
    Campbell XZ, Neet KE.
    J Neurosci Res; 1995 Oct 01; 42(2):207-19. PubMed ID: 8568921
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ, Szepesi A, Domenico J, Tordai A, Terada N, Gelfand EW.
    J Cell Physiol; 1995 Nov 01; 165(2):406-16. PubMed ID: 7593219
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F, Djakiew D.
    Mol Carcinog; 2003 Mar 01; 36(3):153-60. PubMed ID: 12619038
    [Abstract] [Full Text] [Related]

  • 6. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 7. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
    Crowe DL, Shuler CF.
    Cell Growth Differ; 1998 Aug 25; 9(8):619-27. PubMed ID: 9716179
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 25; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US, Park SK, Lee YI, Park JG, Lee YI.
    Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595
    [Abstract] [Full Text] [Related]

  • 11. Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: dissection of the neurotrophic response from the anti-mitogenic response.
    van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL, Rudkin BB.
    Oncogene; 1996 Mar 21; 12(6):1347-56. PubMed ID: 8649837
    [Abstract] [Full Text] [Related]

  • 12. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
    Shima N, Stolz DB, Miyazaki M, Gohda E, Higashio K, Michalopoulos GK.
    J Cell Physiol; 1998 Oct 21; 177(1):130-6. PubMed ID: 9731753
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):873-80. PubMed ID: 9618305
    [Abstract] [Full Text] [Related]

  • 14. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA.
    Oncogene; 1998 Feb 12; 16(6):721-36. PubMed ID: 9488036
    [Abstract] [Full Text] [Related]

  • 15. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 16. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV.
    Oncogene; 1999 Oct 07; 18(41):5611-9. PubMed ID: 10523840
    [Abstract] [Full Text] [Related]

  • 17. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
    Woo CW, Lucarelli E, Thiele CJ.
    Oncogene; 2004 Feb 26; 23(8):1522-30. PubMed ID: 14691455
    [Abstract] [Full Text] [Related]

  • 18. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL.
    Cancer Res; 2001 Sep 01; 61(17):6583-91. PubMed ID: 11522658
    [Abstract] [Full Text] [Related]

  • 19. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
    Sekiguchi T, Hunter T.
    Oncogene; 1998 Jan 22; 16(3):369-80. PubMed ID: 9467962
    [Abstract] [Full Text] [Related]

  • 20. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.